WARNINGOVERDOSE, COMBINATIONS, & WITHDRAWAL CAN BE FATAL
High doses alone or ordinary doses in combination with other depressants can fatally stop breathing. After prolonged dependency, stopping suddenly can cause seizures, delirium, or death.
1,4-Butanediol
1,4-Butanediol is a synthetic diol compound first synthesized in 1890 by Dutch chemist Pieter Johannes Dekkers. Widely used industrially as a solvent and in the manufacture of plastics and polyurethanes,citation needed it also sees recreational use as a depressant.1 It functions as a prodrug for GHB,2 producing reportedly similar effects. It is considered habit-forming1 and carries additional health risks compared to GHB, notably liver toxicity.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Individual response to 1,4-butanediol varies considerably owing to differences in alcohol dehydrogenase enzyme activity. Because effects take longer to manifest than with GHB, premature redosing before the initial dose has taken effect is a frequent contributor to overdose. Recommendations mention starting at 1 mL for new users. Food greatly increases onset time.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Effects vary widely by individual, dose, and context.
Physical
The physical effects of 1,4-butanediol can be broken down into several components which progressively intensify proportional to dosage.
Cognitive
The cognitive effects of 1,4-butanediol can be broken down into several components which progressively intensify proportional to dosage. It contains a large number of typical depressant cognitive effects.
Pharmacology
Pharmacodynamics
1,4-Butanediol functions primarily as a prodrug of gamma-hydroxybutyric acid (GHB), and its major psychoactive effects result from its rapid metabolic conversion into GHB rather than from direct activity of the parent compound.citation needed One study has suggested that 1,4-butanediol may possess inherent alcohol-like pharmacological effects, based on its observed potentiation of ethanol's behavioral effects when co-administered.3 However, this potentiation may instead be explained by competition for shared metabolic enzymes.citation needed A separate study found no effect following direct intracerebroventricular injection in rats, contradicting the hypothesis of inherent pharmacological activity.
Pharmacokinetics
1,4-Butanediol is rapidly converted into GHB by alcohol dehydrogenase and aldehyde dehydrogenase.1 Individual variation in the levels of these enzymes may account for differences in effects and side effects between users.citation needed Because 1,4-butanediol shares its metabolic enzymes with ethanol, co-administration creates competition for these enzymes, slowing the metabolism and clearance of both compounds. The elimination half-life of 1,4-butanediol is approximately 39 minutes.1
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
GHB, GBL, Other GABAergic depressants
Harm Potential
Addiction & Dependence
Psychological
ModerateClassified as habit-forming with potential for psychological dependence characteristic of GABAergic depressants.citation needed
Toxicity
Liver toxicity has been identified as a potential health risk associated with use,1 representing an additional hazard compared to GHB itself.
History & Culture
Discovery and Synthesis
1,4-Butanediol was first synthesized in 1890citation needed by Dutch chemist Pieter Johannes Dekkers through the acidic hydrolysis of N,N'-dinitro-1,4-butanediamine. Dekkers originally named the compound "tetramethylene glycol," a reference to its structure as a four-carbon diol.
Legality
International
1,4-Butanediol is not internationally scheduled under the 1961 Single Convention, the 1971 Convention on Psychotropic Substances, or the 1988 Convention against Illicit Traffic. It is not listed in the convention schedules or the 1988 Convention's Tables I and II.
By Country
References
Source Pages
Citations
- Skryabin, V. Yu., Shevtsova, Yu. B., & Novoselova, E. A.. (2023). Consequences of 1,4-Butanediol Misuse: A Review. Psychopharmacology Bulletin, 53(4), 48-53. https://doi.org/10.64719/pb.447512345
- Goodwin, A. K., Brown, P. R., Jansen, E. E. W., Jakobs, C., Gibson, K. M., & Weerts, E. M.. (2009). Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology, 204(3), 465-476. https://doi.org/10.1007/s00213-009-1477-81
- Flavio Poldrugo, & O. Carter Snead III. (1984). 1,4-butanediol, γ-hydroxybutyric acid and ethanol: Relationships and interactions. Neuropharmacology, 23(1), 109–13. https://doi.org/10.1016/0028-3908(84)90226-01
- Toys Linked To "Date Rape" Drug Pulled. CBS News (n.d.). https://www.cbsnews.com/news/toys-linked-to-date-rape-drug-pulled/1
- Vergiftungen in der TU Darmstadt: K.o.-Tropfen in Uni gefunden. t-online.de (2021). https://www.t-online.de/nachrichten/panorama/kriminalitaet/id_90695568/vergiftungen-in-der-tu-darmstadt-k-o-tropfen-in-uni-gefunden.html1234
- Decreto 128/2026. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/decreto-128-2026-423619/texto1
- Decreto 128/2026. boletinoficial.gob.ar (n.d.). https://www.boletinoficial.gob.ar/detalleAviso/primera/339043/202603041
- Decreto 128/2026. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/ley-23737-138/actualizacion1
- Royal Decree of 6 September 2017 regulating narcotic drugs and/or psychotropic substances. ejustice.just.fgov.be (n.d.). https://www.ejustice.just.fgov.be/eli/besluit/2017/09/06/2017031231/justel1
- Controlled Drugs and Substances Act, Schedule VI, Part 1. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html1
Further Reading
Adverse Events, Including Death, Associated with 1,4-BDO - NEJM (2001)
Clinical Pharmacology of 1,4-BDO (Thai et al., 2007)
DEA Drug Fact Sheet: 1,4-Butanediol (2025)
DEA Drug Fact Sheet: GHB (2020)
Fatal Intoxication Case Report (2023)
GBL & 1,4-BDO ACMD Report (UK Home Office, 2006)
Metabolism Study - PMC (2019)
PubChem Compound Summary: 1,4-Butanediol (2024)
Reddit: /r/researchchemicals Discussion (2019)
Two Cases of Withdrawal - Annals of Emergency Medicine (2001)
WebMD: 1,4-Butanediol
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes8 human edits · latest
Times are UTCNewest first
25 August 2026
Lyrea · Reworded 5 words in Dosage & Duration › Routes 1 › Notes
Lyrea · Changed a word in Dosage & Duration › Routes 1 › Stages › Peak
Lyrea · Changed a word in Dosage & Duration › Routes 1 › Dose ranges › Heavy
Lyrea · Changed a word in Dosage & Duration › Routes 1 › Dose ranges › Strong
Lyrea · Reworded 9 words in Dosage & Duration › Routes 1 › Notes
Lyrea · Changed a word in Dosage & Duration › Routes 1 › Stages › Offset
Lyrea · Changed a word in Dosage & Duration › Routes 1 › Stages › Peak
Lyrea · Changed a word in Dosage & Duration › Routes 1 › Stages › Come up
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 1,4-Butanediol article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.